Event

Collplant Biotechnologies Ltd (CLGN)

Collplant Biotechnologies Ltd (CLGN) Files Form 6-K

Business News

RadNet Inc (RDNT)

DeepHealth Achieves CE Mark for TechLive™ and Enables AWS Marketplace Deployment, Advancing Global Expansion of Multimodality Vendor-Agnostic Remote Scanning Solution

SEC News

LEMAITRE VASCULAR, INC. (LMAT)

📋 LeMaitre George W (Officer) plans to sell 50K shares of LEMAITRE VASCULAR INC (at $113.25 each, total $5.7M) Filed: …


Company Report

MAIA Biotechnology Inc. (MAIA)

Understanding Clinical Trials - Part 1 of 2

FDA Approval

FDA approves LAMOTRIGINE from TORRENT

Final approval of ANDA #ANDA #217100 for LAMOTRIGINE. Decision date: 01/08/2026

About Us

The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.

Our strategies:

  • a combination of various open sources of information with the identification and use of those that provide information most quickly;
  • extracting information mainly by automatic means using artificial intelligence;
  • providing users with structured information with modern available development tools;
  • the use of approaches and tools of machine learning methods to identify the most important events that affect the market;